HERON THERAPEUTICS, INC. /DE/ (HRTX) Operating Income (Loss) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Heron Therapeutics, Inc. /De/ quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
  • Heron Therapeutics, Inc. /De/ Operating Income (Loss) for the quarter ending March 31, 2024 was -$4.8 M, a 85.5% increase year-over-year.
  • Heron Therapeutics, Inc. /De/ Operating Income (Loss) for the twelve months ending March 31, 2024 was -$82.4 M, a 43.1% increase year-over-year.
  • Heron Therapeutics, Inc. /De/ annual Operating Income (Loss) for 2023 was -$111 M, a 36.7% increase from 2022.
  • Heron Therapeutics, Inc. /De/ annual Operating Income (Loss) for 2022 was -$175 M, a 19.8% increase from 2021.
  • Heron Therapeutics, Inc. /De/ annual Operating Income (Loss) for 2021 was -$218 M, a 4.53% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$82.4 M -$4.8 M +$28.3 M +85.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$111 M -$10.2 M +$10.1 M +49.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 -$121 M -$24.9 M +$17 M +40.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$138 M -$42.4 M +$7.1 M +14.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$145 M -$33.1 M +$29.9 M +47.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$175 M -$20.4 M +$33.2 M +62% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$208 M -$41.9 M +$9.83 M +19% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$218 M -$49.5 M +$11 M +18.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$229 M -$62.9 M -$10.8 M -20.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$218 M -$53.5 M +$7.76 M +12.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$226 M -$51.7 M +$6.68 M +11.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$232 M -$60.5 M -$4.72 M -8.47% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$228 M -$52.1 M +$620 K +1.18% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$228 M -$61.3 M -$1.93 M -3.26% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-24
Q3 2020 -$226 M -$58.4 M -$23.5 M -67.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$203 M -$55.7 M -$3.97 M -7.67% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$199 M -$52.7 M +$12 M +18.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$211 M -$59.4 M -$8.05 M -15.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-24
Q3 2019 -$203 M -$34.9 M +$6.93 M +16.6% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-24
Q2 2019 -$210 M -$51.8 M -$12.9 M -33.3% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-24
Q1 2019 -$197 M -$64.7 M -$12.7 M -24.4% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-24
Q4 2018 -$184 M -$51.3 M +$10.6 M +17.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$195 M -$41.8 M -$466 K -1.13% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$194 M -$38.9 M +$3.2 M +7.61% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 -$197 M -$52 M -$2.69 M -5.46% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 -$195 M -$61.9 M -$15.1 M -32.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 -$179 M -$41.3 M +$6.42 M +13.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$186 M -$42.1 M +$1.01 M +2.35% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$187 M -$49.3 M -$16 M -48% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$171 M -$46.8 M -$15.7 M -50.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-22
Q3 2016 -$155 M -$47.7 M -$25.2 M -112% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 -$130 M -$43.1 M -$20.1 M -87.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$110 M -$33.3 M -$13 M -63.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$96.9 M -$31.1 M -$11.6 M -59.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 -$85.4 M -$22.5 M -$3.54 M -18.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$81.8 M -$23 M -$4.22 M -22.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$77.6 M -$20.4 M -$3.04 M -17.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$74.6 M -$19.5 M -$5.66 M -40.9% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-23
Q3 2014 -$68.9 M -$19 M -$6.29 M -49.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$62.6 M -$18.8 M -$3.58 M -23.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$59 M -$17.3 M -$4.57 M -35.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 -$54.5 M -$13.8 M -$5.2 M -60.3% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 -$49.3 M -$12.7 M -$6.61 M -109% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 -$42.6 M -$15.2 M -$10.8 M -247% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 -$31.8 M -$12.8 M -$7.98 M -167% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$23.8 M -$8.63 M -$4.51 M -110% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-13
Q3 2012 -$19.3 M -$6.05 M -$1.97 M -48.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$17.4 M -$4.38 M -$2.84 M -184% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 -$14.5 M -$4.77 M -$3.45 M -263% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$11.1 M -$4.12 M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-07
Q3 2011 -$4.09 M -$2.45 M -150% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-05
Q2 2011 -$1.54 M +$2.16 M +58.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$1.32 M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 -$1.64 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 -$3.7 M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.